We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAAP icon
1301
Corporacion America
CAAP
$4.09B
$148K 0.02%
22,349
-23,698
-51% -$141K
KD icon
1302
Kyndryl
KD
$3.05B
$147K 0.02%
17,835
-40,425
-69% -$420K
FULC icon
1303
Fulcrum Therapeutics
FULC
$297M
$145K 0.02%
17,879
-4,943
-22% -$35.4K
NGM
1304
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$145K 0.02%
+11,059
New +$167K
CDZI icon
1305
Cadiz
CDZI
$291M
$144K 0.02%
75,928
-202,667
-73% -$682K
INVE icon
1306
Identive
INVE
$61.9M
$144K 0.02%
+11,457
New +$157K
REKR icon
1307
Rekor Systems
REKR
$91.7M
$143K 0.02%
142,791
+46,167
+48% +$70.1K
MAGN
1308
Magnera Corp
MAGN
$460M
$142K 0.02%
3,511
+730
+26% +$50.8K
SEEL
1309
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$141K 0.02%
36
+29
+414% +$114K
CNVS icon
1310
Cineverse
CNVS
$65.6M
$140K 0.02%
+17,675
New +$196K
FF icon
1311
Future Fuel
FF
$223M
$140K 0.02%
23,151
-36,044
-61% -$249K
GTHX
1312
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$138K 0.02%
11,042
-192,503
-95% -$2.2M
LFCR icon
1313
Lifecore Biomedical
LFCR
$190M
$137K 0.02%
+15,410
New +$157K
PAGS icon
1314
PagSeguro Digital
PAGS
$2.55B
$137K 0.02%
10,347
-29,733
-74% -$397K
TLRY icon
1315
Tilray
TLRY
$622M
$135K 0.02%
4,906
+2,075
+73% +$72.8K
CLDT
1316
Chatham Lodging
CLDT
$586M
$133K 0.02%
13,489
-42,068
-76% -$506K
GPRK icon
1317
GeoPark
GPRK
$612M
$133K 0.02%
+11,354
New +$140K
FREE
1318
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$133K 0.02%
+34,657
New +$189K
ALEC icon
1319
Alector
ALEC
$199M
$132K 0.02%
+13,995
New +$151K
EXTR icon
1320
Extreme Networks
EXTR
$3.15B
$132K 0.02%
10,099
-184,822
-95% -$2.33M
GOTU icon
1321
Gaotu Techedu
GOTU
$436M
$132K 0.02%
108,821
+48,950
+82% +$79.2K
BCS icon
1322
Barclays
BCS
$94.1B
$131K 0.02%
+20,500
New +$158K
HBI
1323
DELISTED
Hanesbrands
HBI
$131K 0.02%
18,755
+7,756
+71% +$76.2K
NKLA
1324
DELISTED
Nikola Corporation Common Stock
NKLA
$131K 0.02%
1,244
+441
+55% +$74.6K
BMEA icon
1325
Biomea Fusion
BMEA
$91.3M
$129K 0.02%
+13,193
New +$151K

Similar funds

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.